After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Rigel Pharmaceuticals is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Rigel Pharmaceuticals is $696.87M. A total of 0.85 million shares were traded on the day, compared to an average of 433.69K shares.
In the most recent transaction, Schorno Dean L sold 2,036 shares of RIGL for 20.92 per share on Feb 04 ’25. After the transaction, the EVP & Chief Financial Officer now owns 58,969 company shares. In a previous transaction on Feb 05 ’25, Schorno Dean L sold 1,734 shares at 21.93 per share. RIGL shares that EVP & Chief Financial Officer owns now total 57,235.
Among the insiders who sold shares, Santos David A disposed of 2,125 shares on Feb 04 ’25 at a per-share price of $20.92. This resulted in the EVP, Chief Commercial Officer holding 53,500 shares of RIGL after the transaction. In another insider transaction, Santos David A sold 1,796 shares at $21.93 per share on Feb 05 ’25. Company shares held by the EVP, Chief Commercial Officer now total 51,704.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RIGL has a high of $43.72 and a low of $12.66.
As of this writing, RIGL has an earnings estimate of $0.79 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.08 per share and a lower estimate of $0.08. The company reported an EPS of $0.7 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RIGL’s latest balance sheet shows that the firm has $124.97M in Cash & Short Term Investments as of fiscal 2021. There were $30.57M in debt and $63.55M in liabilities at the time. Its Book Value Per Share was $4.57, while its Total Shareholder’s Equity was $30.37M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RIGL is Buy with a score of 3.86.
